Genentech: Press Releases | Saturday, Aug 30, 2025
Saturday, Aug 30, 2025 Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled…
Genentech: Press Releases | Saturday, Aug 30, 2025 Read More